Navigation Links
Dynavax to Present at UBS 2007 Global Life Sciences Conference
Date:9/18/2007

BERKELEY, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) announced today Deborah Smeltzer, Vice President and Chief Financial Officer, will present an overview of the company at the UBS 2007 Global Life Sciences Conference in New York, New York on Tuesday, September 25th at 9:30 a.m. Eastern Daylight Savings Time (6:30 a.m. PDST). The presentation will be webcast.

To access the live audio broadcast and the subsequent archived audio recording of the company presentation, please log onto the company's website at http://www.dynavax.com under the "Investors'" section.

ABOUT DYNAVAX

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative TLR9 agonist-based products to treat and prevent infectious diseases, allergies, cancer, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Our TLR9 agonists are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation. Our product candidates include: HEPLISAV, a hepatitis B vaccine in Phase 3; TOLAMBA(TM), a ragweed allergy immunotherapy; a therapy for non-Hodgkin's lymphoma (NHL) in Phase 2 and for metastatic colorectal cancer in Phase 1; and a therapy for hepatitis B also in Phase 1. Our preclinical asthma and COPD program is partnered with AstraZeneca. The National Institutes of Health (NIH) partially funds our preclinical work on a vaccine for influenza. Symphony Dynamo, Inc. (SDI) funds our colorectal cancer trials and our preclinical hepati
'/>"/>

SOURCE Dynavax Technologies Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 ... regulatory perspectives on nonclinical and clinical safety assessment ... countries to guide a path for biosimilar drug ... the demonstration of biosimilarity with regards to quality, ... specific aspects of biosimilar drug development and registration, ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... of these latent viruses is the Epstein Barr Virus ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... theory, a study found that RA patients have high ... , What is Microcompetition? , Dr. Hanan Polansky discovered ...
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 ... Therapy, an experimental new therapy for the treatment of ... tailor-made for their unique tinnitus frequency, and over a ... , AudioNotch has previously provided Notched Sound Therapy in ... AudioNotch is pleased to announce to release of a ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine ... cells grown under simulated embryonic conditions, today announced ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... (CCM). , This agreement is an ... Suneva Medical, through which Suneva has exclusively licensed ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Based on the clinical success,of its facet replacement ... has expanded its executive management team and established,its ... Massachusetts,allows us to consolidate our operations in one ... gives us access to a wealth of,talent in ...
... Winners of 2008 R&D 100 Awards Now Online, ... the,finalists for the 8th Annual Innovator of the Year ... individuals who exemplify the,ideals of R&D in academia, industry, ... facilitated online with ten finalists,-- five scientists and five ...
... pleased to announce that Dr. Francis Stoessel, a leading ... will be the Keynote Speaker in the Process Safety ... ... Columbia, MD (PRWEB) October ...
Cached Biology Technology:Facet Solutions Establishes Corporate Headquarters and Expands Executive Team 22008 R&D Innovator of the Year & Scientist of the Year Finalists Announced 2
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... become clear that the genetic code is far ... the well-known building blocks adenine, cytosine, guanine, and ... Scientists now assume that the newly discovered nucleic ... information that extends and complements the genetic code. ... extend the standard alphabet," explained Professor Mark Helm ...
(Date:4/15/2014)... Rosemont, IL (April 15, 2014) New research ... Journal of the American College of Nutrition shows ... exercise or as part of a weight-loss or weight-maintenance ... body composition. , The meta-analysis included 14 randomized ... When researchers analyzed those weight loss studies that used ...
Breaking Biology News(10 mins):Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3German Research Foundation approves new priority program in the life sciences 2New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3
... Terrace, Ill., March 8, 2010 Americans recognize things need ... Sam,s efforts to overhaul what is included in their food ... are individually responsible for making the right food choices to ... be successful, according to a new survey by FoodMinds. ...
... the fractious debate on the existence of God and ... the discussion. Taking a perspective rooted in evolutionary biology ... (Prometheus Books, $25) renowned anthropologist Lionel Tiger and pioneering ... is its purpose? How did it arise? What is ...
... problems have to be fed intravenously. There moreover, exist systems ... Mr Iaki Irastorza, paediatrician at the Cruces hospital in Bilbao, ... children were treated at the Great Ormond Street Children,s Hospital ... highly novel PhD thesis at the University of the Basque ...
Cached Biology News:Americans want Uncle Sam's help putting healthy foods on their dinner table 2Which came first: Religion or the brain? 2First time research on long-term consequences of intravenous nutrition on children's health 2First time research on long-term consequences of intravenous nutrition on children's health 3
... analysis kit for 10 chips provides the ... analysis with the Experion automated electrophoresis system. ... 3 x 520 microliters Pro260 gel, 45 ... (10-260 kD), 400 microliters Pro260 sample buffer, ...
... original Gene Pulser apparatus and accessory modules the ... in the Gene Pulser II system, which features ... Gene Pulser II system has the dual advantages ... range of settings to target specific cell types ...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
... Pro260 reagents and supplies, for 10 ... sufficient to perform protein analysis with ... electrophoresis system. Supplied are 3 x ... Pro260 stain, 60 microliters Pro260 ladder ...
Biology Products: